2,3,4,6-tetrachlorophenol has been researched along with Drug Refractory Epilepsy in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karkare, S; Kothare, SV; Shah, YD; Varughese, RT | 1 |
| Fornari Caprara, AL; Rissardo, JP | 1 |
| Wheless, JW | 1 |
| Wang, C; Wang, J; Zhang, L | 1 |
3 review(s) available for 2,3,4,6-tetrachlorophenol and Drug Refractory Epilepsy
| Article | Year |
|---|---|
Cenobamate (YKP3089) and Drug-Resistant Epilepsy: A Review of the Literature.
Topics: Animals; Carbamates; Chlorophenols; Drug Resistant Epilepsy; Seizures; Tetrazoles; United States | 2023 |
Adjunctive cenobamate for the treatment of focal onset seizures in adults with epilepsy: a critical review.
Topics: Adult; Animals; Anticonvulsants; Carbamates; Chlorophenols; Drug Resistant Epilepsy; Humans; Tetrazoles | 2020 |
Efficacy and safety of cenobamate in patients with uncontrolled focal seizures: A meta-analysis.
Topics: Anticonvulsants; Carbamates; Chlorophenols; Dizziness; Dose-Response Relationship, Drug; Drug Resistant Epilepsy; Fatigue; Humans; Nausea; Randomized Controlled Trials as Topic; Seizures; Tetrazoles; Treatment Outcome; Vertigo | 2021 |
1 other study(ies) available for 2,3,4,6-tetrachlorophenol and Drug Refractory Epilepsy
| Article | Year |
|---|---|
Adjunctive use of cenobamate for pediatric refractory focal-onset epilepsy: A single-center retrospective study.
Topics: Adolescent; Adult; Anticonvulsants; Carbamates; Child; Chlorophenols; Drug Resistant Epilepsy; Epilepsies, Partial; Epilepsy; Humans; Retrospective Studies; Seizures; Tetrazoles; Treatment Outcome | 2022 |